• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSZ2400045 重组乙型肝炎疫苗(酿酒酵母) Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) Injection Biological Products License Renew 2024-07-18 GlaxoSmithKline Biologicals SA view
JYSZ2400046 重组乙型肝炎疫苗(酿酒酵母) Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) Injection Biological Products License Renew 2024-07-18 GlaxoSmithKline Biologicals SA view
CYSB2300231 重组乙型肝炎疫苗(酿酒酵母) Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) Injection Biological Products Supplementary Application 2023-12-09 Shenzhen Kangtai Biological Products Co Ltd view
CYSB2300074 重组乙型肝炎疫苗(酿酒酵母) Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) Injection Biological Products Supplementary Application 2023-03-30 Shenzhen Kangtai Biological Products Co Ltd view
JYSB2300038 重组乙型肝炎疫苗(酿酒酵母) Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) Injection Biological Products Supplementary Application 2023-02-23 GlaxoSmithKline Biologicals SA view
JYSB2300037 重组乙型肝炎疫苗(酿酒酵母) Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) Injection Biological Products Supplementary Application 2023-02-23 GlaxoSmithKline Biologicals SA view
CYSB2300038 重组乙型肝炎疫苗(酿酒酵母) Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) Injection Biological Products Supplementary Application 2023-02-13 Beijing Institute of Biological Products Co Ltd view
CYSB2300040 重组乙型肝炎疫苗(酿酒酵母) Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) Injection Biological Products Supplementary Application 2023-02-13 Beijing Institute of Biological Products Co Ltd view
CYSB2300039 重组乙型肝炎疫苗(酿酒酵母) Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) Injection Biological Products Supplementary Application 2023-02-13 Beijing Institute of Biological Products Co Ltd view
JYSB2300006 重组乙型肝炎疫苗(酿酒酵母) Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) Injection Biological Products Supplementary Application 2023-01-14 GlaxoSmithKline Biologicals SA view
JYSB2300007 重组乙型肝炎疫苗(酿酒酵母) Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) Injection Biological Products Supplementary Application 2023-01-14 GlaxoSmithKline Biologicals SA view
JYSB2200113 重组乙型肝炎疫苗(酿酒酵母) Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) Injection Biological Products Supplementary Application 2022-07-02 GlaxoSmithKline Biologicals SA view
JYSB2200112 重组乙型肝炎疫苗(酿酒酵母) Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) Injection Biological Products Supplementary Application 2022-07-02 GlaxoSmithKline Biologicals SA view
JYSB2101077 重组乙型肝炎疫苗(酿酒酵母) Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) Injection Biological Products Supplementary Application 2021-07-05 GlaxoSmithKline Biologicals SA view
JYSB2101078 重组乙型肝炎疫苗(酿酒酵母) Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) Injection Biological Products Supplementary Application 2021-07-05 GlaxoSmithKline Biologicals SA view
JYSB2101075 重组乙型肝炎疫苗(酿酒酵母) Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) Injection Biological Products Supplementary Application 2021-07-02 GlaxoSmithKline Biologicals SA view
JYSB2101076 重组乙型肝炎疫苗(酿酒酵母) Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) Injection Biological Products Supplementary Application 2021-07-02 GlaxoSmithKline Biologicals SA view
JYSB2100056 重组乙型肝炎疫苗(酿酒酵母) Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) Injection Biological Products Supplementary Application 2021-02-23 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd In Review 2021-02-22 view
JYSB2100055 重组乙型肝炎疫苗(酿酒酵母) Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) Injection Biological Products Supplementary Application 2021-02-23 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd In Review 2021-02-22 view
JYSB2100054 重组乙型肝炎疫苗(酿酒酵母) Recombinant Hepatitis B Vaccine(Saccharomyces cerevisiae) Injection Biological Products Supplementary Application 2021-02-23 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd In Review 2021-02-22 view